Becton Dickinson and Co vs Twist Bioscience Corp — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while Twist Bioscience Corp trades at $93.17 (market cap $5.63B). The key difference: Becton Dickinson and Co is far larger — about 7.5× Twist Bioscience Corp's market cap, and Becton Dickinson and Co pays a 2.73% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| BDX | TWST | |
|---|---|---|
Market Cap | $42.39B | $5.63B |
Sector | Health | Health |
52-Week High | $185.39 | $102.88 |
52-Week Low | $135.49 | $24.16 |
Enterprise Value | $58.85B | $5.55B |
Dividend Yield | 2.73% | — |
Trailing returns across standard periods
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →